Enzygnost Anti-HBc/IgM - SFDA Registration ME0000001481SFDAA00846
Access comprehensive regulatory information for Enzygnost Anti-HBc/IgM in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List A device is registered with Saudi Arabia SFDA under registration number ME0000001481SFDAA00846 and manufactured by Siemens Healthcare diagnostics products Gmbh.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
for the qualitative detection of IgM antibodies to hepatitis B
Enzyme immunoassay for the qualitative detection of IgM antibodies to hepatitis B (core) antigen in serum or plasma. The enzyme immunoassay is processed on the BEP® II, BEP® III and BEP® 2000 ELISA processors. The test was developed for investigation of individual samples, not pooled samples. The product is for in‑vitro diagnostic use only.
[]